Deepak Kumar

Dr. Deepak Kumar


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2022 in Medical Principles and Practice
Verified
Journal Article
Open access
PDF file
DMDurga Shankar Meena
Durga Shankar Meena
DKDeepak Kumar
Deepak Kumar
GBGopal Krishana Bohra
Gopal Krishana Bohra
NMNaresh Midha
Naresh Midha
MGMahendra Kumar Garg
Mahendra Kumar Garg
Background: The clinical spectrum of systemic nocardiosis encompasses pulmonary and disseminated disease. Central nervous system (CNS) involvement is an important feature of disseminated disease with significant mortality and high relapse rate, especially in those with suppressed cell-mediated immunity. This systematic review aimed to evaluate the epidemiology, clinical features, diagnosis, therapeutic interventions, and outcome in patients with CNS nocardiosis. Methods: A literature search was performed in major databases (PubMed, Google Scholar, and Scopus) by using distinct keywords: “CNS disease,” “Nocardia,” “meningitis,” “brain abscess,” “disseminated disease,” and “Cotrimoxazole.” We included all patients ≥18 years with CNS nocardiosis reported between January 2000 and December 2020. Results: A total of 129 papers were included in the final analysis. The mean age of patients was 55 ± 16 years, and the majority were male (70.8%). Nocardia farcinica was the commonest species (39.6%), followed by Nocardia nova (5.9%). Thirty-four percent of the patients were found to be immunocompetent. Corticosteroid use was the most common predisposing factor (55.8%). Among neuroimaging findings, brain abscess was most common (86.9%), followed by leptomeningeal enhancement (12.1%). The overall case-fatality rate in CNS disease was 22.8%. On multivariate analysis, patients who underwent surgery (OR 2.4, 95% CI 0.99–4.11, p value 0.046) had better survival than those treated with antimicrobial therapy alone. Immunodeficient state (OR 0.32, 95% CI 0.15–0.90, p value 0.019) was independently associated with poor outcome. Conclusion: CNS nocardiosis carries significant mortality, especially in immunodeficient patients. We advocate the use of surgery combined with antimicrobials to improve clinical outcome.

8 September 2021 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
NPNaveenraj Palanisamy
Naveenraj Palanisamy
NVNakka Vihari
Nakka Vihari
DMDurga Shankar Meena
Durga Shankar Meena
DKDeepak Kumar
Deepak Kumar
NMNaresh Midha
Naresh Midha
SMSanjeev Misra
Sanjeev Misra
Background: Bloodstream infections (BSIs) are an emerging cause of significant morbidity and mortality in severe Coronavirus disease 2019 (COVID-19). We aimed to assess the prevalence, clinical profile and outcome of BSIs in critically ill COVID-19 patients. Methods: This was a single-centre retrospective study conducted at a tertiary care hospital in Western India. All patients (age > 18 years) with reverse-transcription polymerase chain reaction (RT-PCR) confirmed COVID-19 admitted in the intensive care unit (ICU) were included. Hospital electronic records were searched for demographic data, time of bloodstream infection since admission, clinical profile, antimicrobial resistance pattern and clinical outcome of all patients who developed BSIs. Results: Out of 750 patients admitted in COVID ICU, 8.5% developed secondary BSIs. All severe COVID-19 patients who developed BSIs succumbed to illness. A significant proportion of BSIs were Gram-negative pathogens (53/64, 82.8%). Acinetobacter baumannii was the commonest isolate, followed by Klebsiella pneumoniae (32.8% and 21.9%, respectively). Multidrug-resistance organisms (MDRO) were found in 57.8% of the cases. The majority of MDRO belonged to K. pneumoniae and Enterococcus groups. The proportion of Gram-negative bacteria resistant to carbapenems was 47.2% (25/53). On multivariate analysis, raised total leukocyte counts, mechanical ventilation and presence of comorbidities were significantly associated with the incidence of BSIs. Conclusion: We found a significant prevalence of Acinetobacter baumannii in COVID-19 associated BSIs. The presence of comorbidities raised leukocyte counts and mechanical ventilation should alarm clinicians for possible BSIs. The timely initiation of empirical antibiotics and rapid de-escalation is vital to improve the outcome. At the same time, strict compliance of infection control practices should be accomplished to reduce the occurrence of MDRO.

1 November 2021 in Infectious Diseases Now
Verified
Journal Article
Closed access
DMDurga Shankar Meena
Durga Shankar Meena
DKDeepak Kumar
Deepak Kumar
GBGopal Krishana Bohra
Gopal Krishana Bohra
GKGaurav Kumar
Gaurav Kumar

17 November 2021 in Mycoses
Verified
Journal Article
Closed access
PDF file
DMDurga Shankar Meena
Durga Shankar Meena
DKDeepak Kumar
Deepak Kumar
MAMadhulata Agarwal
Madhulata Agarwal
GBGopal Krishana Bohra
Gopal Krishana Bohra
RCRahul Choudhary
Rahul Choudhary
MGMahendra Kumar Garg
Mahendra Kumar Garg

2 June 2023 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
DMDurga Shankar Meena
Durga Shankar Meena
DKDeepak Kumar
Deepak Kumar
MSMukesh Sharma
Mukesh Sharma
MMManika Malik
Manika Malik
ARAkshatha Ravindra
Akshatha Ravindra
MGMahendra Kumar Garg
Mahendra Kumar Garg
Background: CNS actinomycosis is a rare chronic suppurative infection with non-specific clinical features. Diagnosis is difficult due to its similarity to malignancy, nocardiosis and other granulomatous diseases. This systematic review aimed to evaluate the epidemiology, clinical characteristics, diagnostic modalities and treatment outcomes in CNS actinomycosis. Methods: The major electronic databases (PubMed, Google Scholar, and Scopus) were searched for the literature review by using distinct keywords: "CNS" or "intracranial" or "brain abscess" or "meningitis" OR "spinal" OR "epidural abscess" and "actinomycosis." All cases with CNS actinomycosis reported between January 1988 to March 2022 were included. Results: A total of 118 cases of CNS disease were included in the final analysis. The mean age of patients was 44 years, and a significant proportion was male (57%). Actinomycosis israelii was the most prevalent species (41.5%), followed by Actinomyces meyeri (22.6%). Disseminated disease was found in 19.5% of cases. Most commonly involved extra-CNS organs are lung (10.2%) and abdomen (5.1%). Brain abscess (55%) followed by leptomeningeal enhancement (22%) were the most common neuroimaging findings. Culture positivity was found in nearly half of the cases (53.4%). The overall case-fatality rate was 11%. Neurological sequelae were present in 22% of the patients. On multivariate analysis, patients who underwent surgery with antimicrobials had better survival (adjusted OR 0.14, 95% CI 0.04–0.28, p value 0.039) compared to those treated with antimicrobials alone. Conclusion: CNS actinomycosis carries significant morbidity and mortality despite its indolent nature. Early aggressive surgery, along with prolonged antimicrobial treatment is vital to improve outcomes.

25 May 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HSHanwant Singh
Hanwant Singh
SRShani Raj
Shani Raj
DKDeepak Kumar
Deepak Kumar
SSShubhangani Sharma
Shubhangani Sharma
UBUpma Bhatt
Upma Bhatt
VSVineet Soni
Vineet Soni
With growing human culture and industrialization, many pollutants are being introduced into aquatic ecosystems. In recent years, dyes have become a major water pollutant used in the manufacture of paints and other production purposes. In this research, the potential of duckweed (Lemna gibba) plant was investigated spectrophotometrically as an obvious bioagent for the biological decolorization of the organic dye C.I. Basic Green 4 (Malachite Green, BG4). Photosynthetic efficiency analysis showed that the photosynthetic apparatus of L. gibba is very tolerant to BG4. Significant induction of reactive oxygen species (ROS) scavenging enzymes was observed after 24h of biodecolorization process in L. gibba treated with 15 and 30 mg/l BG4. The experimental results showed that L. gibba has a strong ability to extract BG4 from contaminated water and the best results were obtained at 25–30°C and pH 8.0. We conclude that duckweed L. gibba can be used as a potent decolorization organism for BG4.